Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 29.1
(-2.68%)
CNY 29.1
(-2.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 805.08 Million | 8.76 Billion | 10.16 Billion | 3.26 Billion | 367.37 Million | 285.89 Million |
| Cost of Revenue | 640.51 Million | 4.31 Billion | 2.66 Billion | 677.77 Million | 192.85 Million | 146.74 Million |
| Gross Profit | 164.57 Million | 4.45 Billion | 7.5 Billion | 2.58 Billion | 174.52 Million | 139.14 Million |
| Operating Expenses | 736.58 Million | 1.33 Billion | 1.62 Billion | 463.26 Million | 80.05 Million | 65.07 Million |
| Selling, General and Administrative Expenses | 413.18 Million | 600.91 Million | 1.09 Billion | 335.91 Million | 40.36 Million | 34.46 Million |
| Research and Development Expenses | 260.86 Million | 511.56 Million | 428.52 Million | 93.74 Million | 31.75 Million | 18.64 Million |
| Other Expenses | -172.91 Million | 219.87 Million | 98.77 Million | 33.6 Million | 7.93 Million | 1.84 Million |
| Cost and Expenses | 1.2 Billion | 5.64 Billion | 4.28 Billion | 1.14 Billion | 272.91 Million | 211.81 Million |
| Operating Income | -658.17 Million | 3.68 Billion | 5.77 Billion | 1.97 Billion | 91.03 Million | 75.15 Million |
| Interest Expense | 19.25 Million | 6.96 Million | 936.29 Thousand | 44.61 Thousand | 1.69 Million | 3.64 Million |
| Income Tax Expense | 14.04 Million | 373.32 Million | 829.31 Million | 293.95 Million | 13.78 Million | 13.04 Million |
| Earnings before Tax | -404.22 Million | 2.47 Billion | 5.76 Billion | 1.97 Billion | 91.29 Million | 76.99 Million |
| Net Income | -397.58 Million | 2.06 Billion | 4.92 Billion | 1.67 Billion | 82.1 Million | 65.36 Million |
| Earnings Per Share Basic | -1.97 | 12.31 | 34.17 | 8.50 | 0.54 | 0.43 |
| Earnings Per Share Diluted | -1.97 | 12.31 | 34.17 | 8.50 | 0.54 | 0.43 |
| Weighted Average Shares Outstanding | 201.81 Million | 167.97 Million | 144 Million | 197.33 Million | 151.56 Million | 150.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 201.81 Million | 167.97 Million | 144 Million | 197.33 Million | 151.57 Million | 150.43 Million |
| Gross Margin | 0.20 | 0.51 | 0.74 | 0.79 | 0.48 | 0.49 |
| EBIT Margin | -0.25 | 0.43 | 0.58 | 0.64 | 0.28 | 0.31 |
| Profit Margin | -0.49 | 0.24 | 0.48 | 0.51 | 0.22 | 0.23 |
| EBITDA | -199.97 Million | 2.56 Billion | 5.81 Billion | 1.98 Billion | 101.52 Million | 88.2 Million |
| Earnings Before Tax Margin | -0.82 | 0.42 | 0.57 | 0.60 | 0.25 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 239.37 Million | 233.39 Million | 181.74 Million | 805.08 Million | 158.56 Million | 150.62 Million |
| Cost of Revenue | 160.17 Million | 190.67 Million | 123.74 Million | 624.26 Million | 105.74 Million | 86.32 Million |
| Gross Profit | 79.2 Million | 42.72 Million | 58 Million | 180.82 Million | 52.81 Million | 64.3 Million |
| Operating Expenses | 204.43 Million | 189.16 Million | 204.66 Million | 838.99 Million | 440.27 Million | 196.55 Million |
| Selling, General and Administrative Expenses | 335.35 Million | 111.74 Million | 129.44 Million | - | 149.19 Million | 246.8 Million |
| Research and Development Expenses | 63.57 Million | 71.64 Million | 71.96 Million | - | 70.64 Million | 64.39 Million |
| Other Expenses | -194.49 Million | -5.77 Million | -3.25 Million | -172.91 Million | -220.43 Million | -287.59 Thousand |
| Cost and Expenses | 364.61 Million | 379.83 Million | 328.4 Million | 1.46 Billion | 546.02 Million | 282.88 Million |
| Operating Income | -122.76 Million | -146.43 Million | -146.65 Million | -658.17 Million | -387.46 Million | -105.16 Million |
| Interest Expense | 4.07 Million | 6.75 Million | 3.5 Million | 18.12 Million | 6.39 Million | 5.67 Million |
| Income Tax Expense | -6.05 Million | 756.07 Thousand | 1.83 Million | 14.04 Million | -6.98 Million | -243.98 Thousand |
| Earnings before Tax | -120.23 Million | -88.65 Million | -67.25 Million | -402.72 Million | -357.8 Million | -105.45 Million |
| Net Income | -110.54 Million | -84.25 Million | -67.35 Million | -397.58 Million | -325.19 Million | -107.19 Million |
| Earnings Per Share Basic | -0.57 | -0.43 | -0.33 | - | -1.61 | -0.55 |
| Earnings Per Share Diluted | -0.57 | -0.43 | -0.33 | - | -1.61 | -0.53 |
| Weighted Average Shares Outstanding | 193.19 Million | 197.82 Million | 201.6 Million | 201.6 Million | 201.6 Million | 193.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 193.19 Million | 197.82 Million | 201.6 Million | 201.6 Million | 201.6 Million | 201.11 Million |
| Gross Margin | 0.33 | 0.18 | 0.32 | 0.22 | 0.33 | 0.43 |
| EBIT Margin | -0.49 | -0.39 | -0.47 | - | -2.09 | -0.62 |
| Profit Margin | -0.46 | -0.36 | -0.37 | -0.49 | -2.05 | -0.71 |
| EBITDA | -116.16 Million | -91.5 Million | -84.82 Million | - | -332.17 Million | -93.16 Million |
| Earnings Before Tax Margin | -0.51 | -0.63 | -0.81 | -0.82 | -2.44 | -0.70 |
OIBR4
RRKABEL
LLYVA
ABT
IDT
600439